[eGongsi Notice] Kakao, 3Q Operating Profit 150.3 Billion KRW... 10.6% Decrease YoY etc. (Morning Summary)

[Asia Economy Reporter Kwon Jaehee] Kakao announced on the 3rd that its consolidated operating profit for the third quarter of this year was tentatively estimated at 150.3 billion KRW, a 10.6% decrease compared to the same period last year. The operating profit was 13.4% below the market forecast of 173.6 billion KRW. Revenue increased by 6.8% during the same period to 1.8587 trillion KRW. Net profit fell by 84.2% to 137.2 billion KRW.

The following are the major disclosures released that morning.

▲ TYM = Announced on the 3rd that its consolidated operating profit for the third quarter of this year was tentatively estimated at 24.328 billion KRW, a 602.7% increase compared to the same period last year. Revenue increased by 16% to 232.138 billion KRW during the same period.

▲ K Car = Announced on the 3rd that its consolidated operating profit for the third quarter of this year was tentatively estimated at 16.049 billion KRW, a 12.9% decrease compared to the same period last year. Revenue increased by 17.5% to 575.894 billion KRW during the same period.

▲ K Car = K Car announced on the 3rd that it decided to pay a quarterly dividend of 190 KRW per common share in cash. The dividend yield is 1.2%, and the total dividend amount is 9.13644 billion KRW.

▲ SK Innovation = Announced on the 3rd that its consolidated operating profit for the third quarter of this year was tentatively estimated at 704 billion KRW, a 5.28% increase compared to the same period last year. This exceeds the market forecast of 564.2 billion KRW by 24.8%. Revenue increased by 82.49% to 22.7534 trillion KRW during the same period. Net profit decreased by 65.46% to 175.2 billion KRW.

▲ HYBE = Announced on the 3rd that its consolidated operating profit for the third quarter of this year was tentatively estimated at 60.6 billion KRW, a 7.6% decrease compared to the same period last year. Revenue increased by 30.6% to 445.5 billion KRW during the same period. Net profit increased by 90.9% to 94.9 billion KRW.

▲ Cellmat Therapeutics = Announced on the 3rd that outside directors Kim Sang-tae and Kim Hwa-young voluntarily resigned due to personal reasons, reducing the total number of outside directors from 4 to 2.